221 related articles for article (PubMed ID: 30176322)
1. Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model.
Rojewska E; Wawrzczak-Bargiela A; Szucs E; Benyhe S; Starnowska J; Mika J; Przewlocki R; Przewlocka B
Neuroscience; 2018 Oct; 390():293-302. PubMed ID: 30176322
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptors mRNAs expression and opioids agonist-dependent G-protein activation in the rat brain following neuropathy.
Llorca-Torralba M; Pilar-Cuéllar F; da Silva Borges G; Mico JA; Berrocoso E
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109857. PubMed ID: 31904442
[TBL] [Abstract][Full Text] [Related]
3. Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
Rutten K; Schröder W; Christoph T; Koch T; Tzschentke TM
Eur J Pharmacol; 2018 May; 827():41-48. PubMed ID: 29524385
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of left and right neuropathy on opioid gene expression in lumbar spinal cord.
Kononenko O; Mityakina I; Galatenko V; Watanabe H; Bazov I; Gerashchenko A; Sarkisyan D; Iatsyshyna A; Yakovleva T; Tonevitsky A; Marklund N; Ossipov MH; Bakalkin G
Brain Res; 2018 Sep; 1695():78-83. PubMed ID: 29852138
[TBL] [Abstract][Full Text] [Related]
5. Bilateral and differential changes in spinal mu, delta and kappa opioid binding in rats with a painful, unilateral neuropathy.
Stevens CW; Kajander KC; Bennett GJ; Seybold VS
Pain; 1991 Sep; 46(3):315-326. PubMed ID: 1661886
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505).
Dietis N; McDonald J; Molinari S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
Br J Anaesth; 2012 Feb; 108(2):262-70. PubMed ID: 22194444
[TBL] [Abstract][Full Text] [Related]
7. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S
Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279
[TBL] [Abstract][Full Text] [Related]
8. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
Zaveri NT; Journigan VB; Polgar WE
ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
[TBL] [Abstract][Full Text] [Related]
10. Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.
Starnowska J; Costante R; Guillemyn K; Popiolek-Barczyk K; Chung NN; Lemieux C; Keresztes A; Van Duppen J; Mollica A; Streicher J; Vanden Broeck J; Schiller PW; Tourwé D; Mika J; Ballet S; Przewlocka B
ACS Chem Neurosci; 2017 Oct; 8(10):2315-2324. PubMed ID: 28699350
[TBL] [Abstract][Full Text] [Related]
11. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
Bird MF; Vardanyan RS; Hruby VJ; Calò G; Guerrini R; Salvadori S; Trapella C; McDonald J; Rowbotham DJ; Lambert DG
Br J Anaesth; 2015 Apr; 114(4):646-56. PubMed ID: 25680364
[TBL] [Abstract][Full Text] [Related]
12. The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalins.
Cabañero D; Célérier E; García-Nogales P; Mata M; Roques BP; Maldonado R; Puig MM
Pain; 2009 Jan; 141(1-2):88-96. PubMed ID: 19058913
[TBL] [Abstract][Full Text] [Related]
13. Changes in the circadian rhythm of mRNA expression for µ-opioid receptors in the periaqueductal gray under a neuropathic pain-like state.
Takada T; Yamashita A; Date A; Yanase M; Suhara Y; Hamada A; Sakai H; Ikegami D; Iseki M; Inada E; Narita M
Synapse; 2013 May; 67(5):216-23. PubMed ID: 23280810
[TBL] [Abstract][Full Text] [Related]
14. Evidence for nociceptin/orphanin FQ (NOP) but not µ (MOP), δ (DOP) or κ (KOP) opioid receptor mRNA in whole human blood.
Al-Hashimi M; McDonald J; Thompson JP; Lambert DG
Br J Anaesth; 2016 Mar; 116(3):423-9. PubMed ID: 26865135
[TBL] [Abstract][Full Text] [Related]
15. κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain.
Megat S; Bohren Y; Doridot S; Gaveriaux-Ruff C; Kieffer BL; Freund-Mercier MJ; Yalcin I; Barrot M
Br J Pharmacol; 2015 Feb; 172(4):1034-44. PubMed ID: 25297905
[TBL] [Abstract][Full Text] [Related]
16. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
17. Dynorphinergic system alterations in the corticostriatal circuitry of neuropathic mice support its role in the negative affective component of pain.
Palmisano M; Caputi FF; Mercatelli D; Romualdi P; Candeletti S
Genes Brain Behav; 2019 Jul; 18(6):e12467. PubMed ID: 29430855
[TBL] [Abstract][Full Text] [Related]
18. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
Narita M; Miyoshi K; Narita M; Suzuki T
Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
[TBL] [Abstract][Full Text] [Related]
19. Role of spinal opioid receptor on the antiallodynic effect of intrathecal nociceptin in neuropathic rat.
Ju J; Shin DJ; Na YC; Yoon MH
Neurosci Lett; 2013 May; 542():118-22. PubMed ID: 23545207
[TBL] [Abstract][Full Text] [Related]
20. Mu and delta opioid receptors play opposite nociceptive and behavioural roles on nerve-injured mice.
Martínez-Navarro M; Cabañero D; Wawrzczak-Bargiela A; Robe A; Gavériaux-Ruff C; Kieffer BL; Przewlocki R; Baños JE; Maldonado R
Br J Pharmacol; 2020 Mar; 177(5):1187-1205. PubMed ID: 31655493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
